HK Stock MarketDetailed Quotes

00241 ALI HEALTH

Watchlist
  • 3.580
  • -0.100-2.72%
Trading Nov 28 14:30 CST
57.61BMarket Cap43.13P/E (TTM)

ALI HEALTH Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Sep 30, 2024
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
(Q6)Sep 30, 2020
(FY)Mar 31, 2020
Turnover
10.17%14.27B
0.98%27.03B
12.66%12.96B
30.06%26.76B
22.90%11.5B
32.60%20.58B
30.66%9.36B
61.71%15.52B
73.97%7.16B
88.32%9.6B
Operating income
10.17%14.27B
0.98%27.03B
12.66%12.96B
30.06%26.76B
22.90%11.5B
32.60%20.58B
30.66%9.36B
61.71%15.52B
73.97%7.16B
88.32%9.6B
Cost of sales
-6.47%-10.74B
-0.33%-21.13B
-9.65%-10.09B
-27.88%-21.06B
-22.88%-9.2B
-38.39%-16.47B
-41.22%-7.49B
-61.59%-11.9B
-71.84%-5.3B
-95.64%-7.37B
Operating expenses
-6.47%-10.74B
-0.33%-21.13B
-9.65%-10.09B
-27.88%-21.06B
-22.88%-9.2B
-38.39%-16.47B
-41.22%-7.49B
-61.59%-11.9B
-71.84%-5.3B
-95.64%-7.37B
Gross profit
23.18%3.53B
3.40%5.9B
24.69%2.87B
38.79%5.7B
22.98%2.3B
13.57%4.11B
0.56%1.87B
62.11%3.62B
80.32%1.86B
67.61%2.23B
Selling expenses
-12.80%-980.7M
-0.45%-1.78B
-1.22%-869.38M
10.73%-1.77B
12.69%-858.89M
-62.13%-1.98B
-93.36%-983.71M
-69.08%-1.22B
-52.66%-508.74M
-58.90%-722.72M
Administrative expenses
-7.87%-182.87M
5.14%-359.98M
2.20%-169.53M
3.95%-379.49M
-1.65%-173.34M
-34.57%-395.08M
-19.25%-170.53M
-33.47%-293.6M
-36.10%-143M
-21.52%-219.97M
Research and development expenses
0.03%-319.22M
-4.07%-705.38M
1.44%-319.31M
7.00%-677.82M
-0.38%-323.99M
-72.04%-728.83M
-40.66%-322.75M
-67.55%-423.63M
-69.79%-229.45M
-15.44%-252.84M
Operating interest expense
----
----
----
----
-356.17%-3.36M
-55.78%-3.82M
53.35%-737K
88.85%-2.45M
91.88%-1.58M
---21.97M
Special items of operating profit
-18.50%-1.21B
9.78%-2.1B
-32.71%-1.02B
-93.21%-2.33B
-28.23%-767.49M
2.43%-1.21B
2.55%-598.52M
-27.32%-1.24B
-50.05%-614.21M
-91.24%-970.75M
Operating profit
71.58%844.01M
74.41%951.29M
183.38%491.92M
363.64%545.45M
184.48%173.59M
-147.06%-206.89M
-156.55%-205.48M
919.41%439.63M
1,136.28%363.34M
238.14%43.13M
Financing cost
39.46%-1.49M
-2.33%-5.97M
---2.45M
---5.83M
----
----
----
----
----
----
Share of profits of associates
-17.28%-11.47M
81.48%-6.97M
50.02%-9.78M
19.81%-37.6M
23.91%-19.57M
-74.59%-46.89M
22.56%-25.71M
-26.12%-26.86M
-80.30%-33.21M
-2,247.85%-21.3M
Share of profit from joint venture company
-728.59%-9.98M
-97.88%1.04M
-92.04%1.59M
3,759.81%48.98M
1,401.28%19.95M
110.98%1.27M
123.34%1.33M
9.27%-11.56M
-6.55%-5.69M
-1,628.22%-12.74M
Earning before tax
70.60%821.07M
70.49%939.4M
176.63%481.27M
318.20%550.99M
175.69%173.98M
-162.94%-252.51M
-170.85%-229.86M
4,311.91%401.22M
5,664.77%324.44M
114.95%9.09M
Tax
-43.99%-52.02M
-288.42%-56.26M
-245.19%-36.13M
-7.88%-14.49M
-513.48%-10.47M
77.06%-13.43M
96.28%-1.71M
-136.14%-58.54M
-246.13%-45.89M
19.86%-24.79M
After-tax profit from continuing operations
72.76%769.05M
64.61%883.14M
172.24%445.14M
301.74%536.51M
170.61%163.51M
-177.61%-265.94M
-183.13%-231.57M
2,283.23%342.68M
3,751.25%278.55M
82.90%-15.7M
Earning after tax
72.76%769.05M
64.61%883.14M
172.24%445.14M
301.74%536.51M
170.61%163.51M
-177.61%-265.94M
-183.13%-231.57M
2,283.23%342.68M
3,751.25%278.55M
82.90%-15.7M
Minority profit
112.70%95K
-139.84%-341K
-156.88%-748K
321.76%856K
547.78%1.32M
93.47%-386K
104.16%203K
35.15%-5.91M
25.28%-4.88M
7.18%-9.11M
Profit attributable to shareholders
72.45%768.95M
64.93%883.48M
174.91%445.89M
301.71%535.65M
169.98%162.19M
-176.18%-265.56M
-181.77%-231.77M
5,392.86%348.59M
25,819.69%283.43M
91.96%-6.59M
Basic earnings per share
45.15%0.0479
58.44%0.0629
175.00%0.033
301.52%0.0397
169.77%0.012
-174.90%-0.0197
-179.26%-0.0172
4,483.33%0.0263
21,800.00%0.0217
91.89%-0.0006
Diluted earnings per share
45.29%0.0478
58.33%0.0627
174.17%0.0329
301.02%0.0396
169.77%0.012
-175.19%-0.0197
-179.63%-0.0172
4,466.67%0.0262
21,700.00%0.0216
91.89%-0.0006
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Sep 30, 2024(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021(Q6)Sep 30, 2020(FY)Mar 31, 2020
Turnover 10.17%14.27B0.98%27.03B12.66%12.96B30.06%26.76B22.90%11.5B32.60%20.58B30.66%9.36B61.71%15.52B73.97%7.16B88.32%9.6B
Operating income 10.17%14.27B0.98%27.03B12.66%12.96B30.06%26.76B22.90%11.5B32.60%20.58B30.66%9.36B61.71%15.52B73.97%7.16B88.32%9.6B
Cost of sales -6.47%-10.74B-0.33%-21.13B-9.65%-10.09B-27.88%-21.06B-22.88%-9.2B-38.39%-16.47B-41.22%-7.49B-61.59%-11.9B-71.84%-5.3B-95.64%-7.37B
Operating expenses -6.47%-10.74B-0.33%-21.13B-9.65%-10.09B-27.88%-21.06B-22.88%-9.2B-38.39%-16.47B-41.22%-7.49B-61.59%-11.9B-71.84%-5.3B-95.64%-7.37B
Gross profit 23.18%3.53B3.40%5.9B24.69%2.87B38.79%5.7B22.98%2.3B13.57%4.11B0.56%1.87B62.11%3.62B80.32%1.86B67.61%2.23B
Selling expenses -12.80%-980.7M-0.45%-1.78B-1.22%-869.38M10.73%-1.77B12.69%-858.89M-62.13%-1.98B-93.36%-983.71M-69.08%-1.22B-52.66%-508.74M-58.90%-722.72M
Administrative expenses -7.87%-182.87M5.14%-359.98M2.20%-169.53M3.95%-379.49M-1.65%-173.34M-34.57%-395.08M-19.25%-170.53M-33.47%-293.6M-36.10%-143M-21.52%-219.97M
Research and development expenses 0.03%-319.22M-4.07%-705.38M1.44%-319.31M7.00%-677.82M-0.38%-323.99M-72.04%-728.83M-40.66%-322.75M-67.55%-423.63M-69.79%-229.45M-15.44%-252.84M
Operating interest expense -----------------356.17%-3.36M-55.78%-3.82M53.35%-737K88.85%-2.45M91.88%-1.58M---21.97M
Special items of operating profit -18.50%-1.21B9.78%-2.1B-32.71%-1.02B-93.21%-2.33B-28.23%-767.49M2.43%-1.21B2.55%-598.52M-27.32%-1.24B-50.05%-614.21M-91.24%-970.75M
Operating profit 71.58%844.01M74.41%951.29M183.38%491.92M363.64%545.45M184.48%173.59M-147.06%-206.89M-156.55%-205.48M919.41%439.63M1,136.28%363.34M238.14%43.13M
Financing cost 39.46%-1.49M-2.33%-5.97M---2.45M---5.83M------------------------
Share of profits of associates -17.28%-11.47M81.48%-6.97M50.02%-9.78M19.81%-37.6M23.91%-19.57M-74.59%-46.89M22.56%-25.71M-26.12%-26.86M-80.30%-33.21M-2,247.85%-21.3M
Share of profit from joint venture company -728.59%-9.98M-97.88%1.04M-92.04%1.59M3,759.81%48.98M1,401.28%19.95M110.98%1.27M123.34%1.33M9.27%-11.56M-6.55%-5.69M-1,628.22%-12.74M
Earning before tax 70.60%821.07M70.49%939.4M176.63%481.27M318.20%550.99M175.69%173.98M-162.94%-252.51M-170.85%-229.86M4,311.91%401.22M5,664.77%324.44M114.95%9.09M
Tax -43.99%-52.02M-288.42%-56.26M-245.19%-36.13M-7.88%-14.49M-513.48%-10.47M77.06%-13.43M96.28%-1.71M-136.14%-58.54M-246.13%-45.89M19.86%-24.79M
After-tax profit from continuing operations 72.76%769.05M64.61%883.14M172.24%445.14M301.74%536.51M170.61%163.51M-177.61%-265.94M-183.13%-231.57M2,283.23%342.68M3,751.25%278.55M82.90%-15.7M
Earning after tax 72.76%769.05M64.61%883.14M172.24%445.14M301.74%536.51M170.61%163.51M-177.61%-265.94M-183.13%-231.57M2,283.23%342.68M3,751.25%278.55M82.90%-15.7M
Minority profit 112.70%95K-139.84%-341K-156.88%-748K321.76%856K547.78%1.32M93.47%-386K104.16%203K35.15%-5.91M25.28%-4.88M7.18%-9.11M
Profit attributable to shareholders 72.45%768.95M64.93%883.48M174.91%445.89M301.71%535.65M169.98%162.19M-176.18%-265.56M-181.77%-231.77M5,392.86%348.59M25,819.69%283.43M91.96%-6.59M
Basic earnings per share 45.15%0.047958.44%0.0629175.00%0.033301.52%0.0397169.77%0.012-174.90%-0.0197-179.26%-0.01724,483.33%0.026321,800.00%0.021791.89%-0.0006
Diluted earnings per share 45.29%0.047858.33%0.0627174.17%0.0329301.02%0.0396169.77%0.012-175.19%-0.0197-179.63%-0.01724,466.67%0.026221,700.00%0.021691.89%-0.0006
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data